Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (Q73336405)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 2000

Language	Label	Description	Also known as
English	Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis	scientific article published on 01 January 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

experimental autoimmune encephalomyelitis

0 references

multiple sclerosis

1 reference

based on heuristic

inferred from title

author name string

A Achiron

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Miron

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

V Lavie

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Margalit

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Biegon

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Journal of Neuroimmunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

102

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

26-31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel nonpsychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood-brain barrier disruption in photochemical cortical infarction in rats: a quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential Inhibition of RAW264.7 Macrophage Tumoricidal Activity by 9Tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Follow-up study of MS patients treated with high-dose intravenous methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Enantiomeric cannabinoids: stereospecificity of psychotropic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of experimental autoimmune encephalomyelitis by cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900149-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0165-5728(99)00149-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626663%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73336405&oldid=1753400061"